Valeant

Page 8 of 12

House Oversight Hearing On Prescription Drug Price Increases
Finance

Why Valeant’s Stock Surged After CEO Admitted ‘Mistakes’

By
February 23, 2016
Senate Permanent Subcommittee On Investigations Hearing On U.S. Corporate Tax Code
Finance

Here’s Why Valeant Shares Are Plunging Again

By
February 23, 2016
Views Of A CVS Caremark Corp. Store Ahead Of Earns
Health

CVS Just Made Valeant’s Day Even Worse

By
February 22, 2016
The headquarters of Valeant Pharmaceuticals International, Inc. stands in Bridgewater Township, U.S., on Wednesday Nov. 04, 2015. Photographer: Michael Nagle/Bloomberg
Finance

Here’s Why Shares of Valeant Have Plunged for Their Second Straight Day

By
February 22, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance

Bill Ackman Bought More Valeant

By
February 17, 2016
Squawk Box - Season 20
Finance

Here’s What Wall Street Thinks of Bill Ackman’s New Herbalife Attack

By
February 9, 2016
House Oversight Hearing On Prescription Drug Price Increases
Health

How Martin Shkreli Is ‘Trashing’ the Pharma Industry

By
February 4, 2016
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance

Biotech Stocks Crashed and Nobody Knows Why

By
January 29, 2016
Ackman, founder and CEO of hedge fund Pershing Square Capital Management, speaks at the Sohn Investment Conference in New York
Finance

Bill Ackman to World: Not my Fault

By
January 28, 2016
valeant ceo michael pearson
Leadership

Valeant’s CEO Isn’t Sure When He’ll Return from Medical Leave

By
January 25, 2016
Senate Permanent Subcommittee On Investigations Hearing On U.S. Corporate Tax Code
Health

Valeant Vows to Make Its Drugs ‘Affordable’

By
January 13, 2016
Walgreens Defends its Deal with Valeant
Health

Walgreens Defends its Deal with Valeant

By
January 7, 2016
Senate Permanent Subcommittee On Investigations Hearing On U.S. Corporate Tax Code
Health

Valeant Appoints Howard Schiller Interim CEO

By
January 6, 2016
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Leadership

Valeant Will Be Run by a Group of Executives Until Its CEO Returns

By
December 28, 2015
VW Automobile Assembly
Leadership

The 5 Biggest Corporate Scandals of 2015

By Chris Matthews and Stephen Gandel
December 27, 2015

Most Popular